Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results

Go back to Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results
(NASDAQ: CRXT) Delayed: 0.10 --0 (-0%)
Previous Close $0.10    52 Week High
Open $0.17    52 Week Low
Day High $0.10    P/E N/A 
Day Low $0.10    EPS
Volume 13,955       

(NASDAQ: CRXTW) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High
Open $1.08    52 Week Low
Day High $0.01    P/E N/A 
Day Low $0.01    EPS
Volume 734,363